IsoRay Medical, Inc. the sole manufacturer and distributor of Cesium-131 isotope seeds used in brachytherapy for the treatment of prostate cancer, will be expanding its production capabilities with the opening of a new facility in Richland.

Aug. 4--Richland-based IsoRay Medical has become a publicly traded company, with plans to raise $10 million to $20 million to build a new production facility for its isotope cancer treatment technology. IsoRay Inc.

Interim Facility Sets Stage for Multi-State Review of Permanent Sites IsoRay Medical, Inc., a developer, manufacturer and marketer of medical isotopes, has signed an agreement establishing interim production facilities through Pacific EcoSolutions, Inc.